American Red Cross
Records under this name other than patents American Red Cross holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,192,702 | Modulators of the Interaction Between ARP2/3 and Cortactin or HS-1 Formerly held Term ended Term ended Mar 18, 2023 · High confidence | Term ended | Term ended Mar 18, 2023 | High confidence |
| US 7,906,500 | Novel Chalcogenoxanthylium Dyes for Purging Blood Pathogens and for Photodynamic Therapy Formerly held Lapsed on the fee record Ended Mar 15, 2023 · High confidence | Lapsed on the fee record | Ended Mar 15, 2023 | High confidence |
| US 6,906,026 | Methods for treating conditions associated with the accumulation of excess extracellular matrix Formerly held Term ended Term ended Jul 20, 2021 · From the USPTO record | Term ended | Term ended Jul 20, 2021 | From the USPTO record |
| US 7,087,574 | Brain associated inhibitor of tissue-type plasminogen activator Term ended Term ended Jun 6, 2020 · From the USPTO record | Term ended | Term ended Jun 6, 2020 | From the USPTO record |
| US 6,191,260 | Brain-associated inhibitor of tissue-type plasminogen activator Term ended Term ended Jul 8, 2019 · From the USPTO record | Term ended | Term ended Jul 8, 2019 | From the USPTO record |
| US 6,093,804 | Method for purification of alpha-1 proteinase inhibitor Formerly held Term ended Term ended Sep 24, 2018 · From the USPTO record | Term ended | Term ended Sep 24, 2018 | From the USPTO record |
| US 6,984,772 | Transgenic non-human mammals producing fibrinogen in their milk Lapsed on the fee record Ended Jan 10, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jan 10, 2018 | From the USPTO record |
| US 7,419,948 | Treatment of hemophilia with human Factor IX produced in mammary tissue of transgenic mammals Lapsed on the fee record Ended Sep 2, 2016 · From the USPTO record | Lapsed on the fee record | Ended Sep 2, 2016 | From the USPTO record |
| US 7,211,559 | Factor VIII Compositions and Methods Formerly held Lapsed on the fee record Ended May 1, 2015 · High confidence | Lapsed on the fee record | Ended May 1, 2015 | High confidence |
| US 6,344,596 | Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals Formerly held Lapsed on the fee record Ended Feb 5, 2014 · From the USPTO record | Lapsed on the fee record | Ended Feb 5, 2014 | From the USPTO record |